Home › Trial NCT01127386
Lenalidomide for Lean Body Mass and Muscle Strength in Inflammatory Cancer Cachexia Syndrome
- Trial IDNCT01127386
- StatusCompleted
- PhasePhase 1/2
- Study typeInterventional
- SponsorFlorian Strasser, MD ABHPM
- Enrollment200
- Start date2009-03
- ConditionsCancer Cachexia Syndrome
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.